---
title: "Tectonic Therapeutic, Inc. (TECX.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/TECX.US.md"
symbol: "TECX.US"
name: "Tectonic Therapeutic, Inc."
industry: "Biotechnology"
---

# Tectonic Therapeutic, Inc. (TECX.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Location | US Market |
| Website | [ectonictx.com](https://ectonictx.com) |

## Company Profile

Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein-coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologi...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -6.66 | 404/602 | - | - | - |
| PB | 1.67 | 144/602 | 1.74 | 1.40 | 1.23 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-25T05:00:00.000Z

Total Analysts: **9**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 7 | 78% |
| Overweight | 2 | 22% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 30.84 |
| Highest Target | 112.00 |
| Lowest Target | 69.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/TECX.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/TECX.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/TECX.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.